IL43927A - Lysino-calcium chloride and acid addition salts thereof their preparation and pharmaceutical compositions containing them - Google Patents

Lysino-calcium chloride and acid addition salts thereof their preparation and pharmaceutical compositions containing them

Info

Publication number
IL43927A
IL43927A IL43927A IL4392773A IL43927A IL 43927 A IL43927 A IL 43927A IL 43927 A IL43927 A IL 43927A IL 4392773 A IL4392773 A IL 4392773A IL 43927 A IL43927 A IL 43927A
Authority
IL
Israel
Prior art keywords
lysino
calcium chloride
namely
calcium
salt
Prior art date
Application number
IL43927A
Other languages
English (en)
Other versions
IL43927A0 (en
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IL43927A0 publication Critical patent/IL43927A0/xx
Publication of IL43927A publication Critical patent/IL43927A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL43927A 1973-01-02 1973-12-28 Lysino-calcium chloride and acid addition salts thereof their preparation and pharmaceutical compositions containing them IL43927A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB19273*[A GB1394757A (en) 1973-01-02 1973-01-02 Lysino-calcium chloride

Publications (2)

Publication Number Publication Date
IL43927A0 IL43927A0 (en) 1974-03-14
IL43927A true IL43927A (en) 1976-10-31

Family

ID=9700038

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43927A IL43927A (en) 1973-01-02 1973-12-28 Lysino-calcium chloride and acid addition salts thereof their preparation and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (1) US3928506A (ja)
JP (1) JPS5810377B2 (ja)
AR (1) AR200042A1 (ja)
AT (1) AT323125B (ja)
AU (1) AU475433B2 (ja)
BE (1) BE809324A (ja)
CA (1) CA1000288A (ja)
CH (1) CH591422A5 (ja)
CS (1) CS174121B2 (ja)
DD (1) DD110488A5 (ja)
DE (1) DE2364704C2 (ja)
ES (1) ES421854A1 (ja)
FR (1) FR2212151B1 (ja)
GB (1) GB1394757A (ja)
HK (1) HK23376A (ja)
HU (1) HU168134B (ja)
IL (1) IL43927A (ja)
IN (1) IN140693B (ja)
NL (1) NL179277C (ja)
PL (1) PL89632B1 (ja)
RO (1) RO64583A (ja)
SE (1) SE398874B (ja)
SU (1) SU504479A3 (ja)
YU (1) YU36152B (ja)
ZA (1) ZA739698B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948594A (en) * 1989-01-03 1990-08-14 Zinpro Corporation Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements
US4900561A (en) * 1989-01-03 1990-02-13 Zinpro Corporation Copper complexes of alpha-amino acids that contain terminal amino groups, and their use as nutritional supplements
US5885610A (en) * 1997-03-04 1999-03-23 Zinpro Corporation By-pass rumen product
US6294207B1 (en) * 1999-11-01 2001-09-25 Albion International, Inc. Calcium fortification of oleaginous foods
AR055285A1 (es) * 2005-11-11 2007-08-15 Edgardo Adrian Hager Sales de nutrientes minerales estabilizados con aminoacidos productos y suplemento alimenticio que las comprenden y procedimientos de obtencion
CN105777534B (zh) * 2014-12-24 2018-07-06 辽宁科硕营养科技有限公司 柠檬酸钙盐及其制备方法与用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2386273A (en) * 1943-01-15 1945-10-09 Lilly Co Eli Carbonates of 1-r-1 aminoethanes
US2833821A (en) * 1954-10-07 1958-05-06 Du Pont Preparation of calcium lysinate
US3010972A (en) * 1960-03-18 1961-11-28 Smith Kline French Lab Condensed cyclopropyl amine derivatives
US3355488A (en) * 1964-04-13 1967-11-28 Squibb & Sons Inc Calcium chloride salt of penicillamine

Also Published As

Publication number Publication date
NL179277C (nl) 1986-08-18
AU475433B2 (en) 1976-08-19
GB1394757A (en) 1975-05-21
IL43927A0 (en) 1974-03-14
NL7317589A (ja) 1974-07-04
CH591422A5 (ja) 1977-09-15
YU36152B (en) 1982-02-25
YU338573A (en) 1981-06-30
JPS5810377B2 (ja) 1983-02-25
IN140693B (ja) 1976-12-11
SE398874B (sv) 1978-01-23
BE809324A (fr) 1974-07-02
DE2364704A1 (de) 1974-09-05
CS174121B2 (ja) 1977-03-31
HU168134B (ja) 1976-02-28
AR200042A1 (es) 1974-10-15
ES421854A1 (es) 1976-08-01
AU6394573A (en) 1975-07-03
SU504479A3 (ru) 1976-02-25
NL179277B (nl) 1986-03-17
US3928506A (en) 1975-12-23
DE2364704C2 (de) 1985-03-21
CA1000288A (en) 1976-11-23
ZA739698B (en) 1974-11-27
FR2212151A1 (ja) 1974-07-26
PL89632B1 (ja) 1976-11-30
FR2212151B1 (ja) 1978-01-06
AT323125B (de) 1975-06-25
DD110488A5 (ja) 1974-12-20
RO64583A (fr) 1978-07-15
JPS49100214A (ja) 1974-09-21
HK23376A (en) 1976-04-30

Similar Documents

Publication Publication Date Title
EP0491864B1 (en) Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
KR100745160B1 (ko) 멜도늄 염, 그것의 제조방법 및 그것을 주성분으로 한약학적 조성물
US20220055980A1 (en) Treprostinil derivatives and compositions and uses thereof
IL43927A (en) Lysino-calcium chloride and acid addition salts thereof their preparation and pharmaceutical compositions containing them
AP2004003160A0 (en) Tolterodine salts
ZA200600617B (en) Meldonium salts, method of their preparation and pharmaceutical composition on their basis
ES2557598T3 (es) Agente anti-XDR-TB, agente anti-MDR-TB y agente antituberculoso combinado
EA020303B1 (ru) Применение 4-[этил(диметил)аммонио]бутаноата для лечения сердечно-сосудистых заболеваний
ES2322263T3 (es) Mitroxiderivados de enalapril y compuestos relacionados con inhibidores de ace, para el tratamiento de enfermedades cardiovasculares.
US5268361A (en) Hydroxyazido derivatives and related compounds as renin inhibitors
JP7526734B2 (ja) アルギナーゼインヒビタ及びその使用方法
US3804820A (en) N-(substituted-alpha-penicilloyl)-amino carboxylic acids
CN110741003B (zh) 作为gls1抑制剂的化合物
JPH02202899A (ja) 酵素阻害作用を有するジペプチド誘導体
US4189499A (en) Lysine 4-allyloxy-3-chlorophenylacetate and method of its preparation
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
Durbin et al. Exchange diffusion of chloride in frog gastric mucosa
JP4006598B2 (ja) ペプチド誘導体及びその薬学的に許容される塩、その製造法並びにその用途
FR2318636A1 (fr) Procede d'obtention de preparations pharmaceutiques stables pour usage oral, contenant des derives d'homopyrimidazole
PRESENT PHARMACEUTICAL TABLET FOR THE TREATMENT OF URAEMIA
US2498618A (en) Polyglycol sulfate salts of diaminodiphenyl sulfone and preparation thereof
EA044999B1 (ru) Ингибиторы аргиназы и способы их применения
GB894752A (en) Improvements in or relating to citric acid derivatives
GB656500A (en) Improvements in or relating to the preparation of l-arterenol and l-arterenol so prepared